Protective effect of ulinastatin on lung tissues of esophageal carcinoma patients who underwent esophagectomy

Gong-chao WANG,Chun-qin WANG,Ai-chun PAN,Zhou WANG
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2009.02.002
2009-01-01
Abstract:Objective: To investigate the protective effect of ulinastatin on inflammatory reaction in patients who underwent esophagectomy. Methods: Eighty esophageal carcinoma patients were randomly divided into two groups (n=40 each), a ulinastatin group and control group. The ulinastatin group recevied 2 × 105 units of ulinastatin continuosly for 3 days before the operation and 7 days after the operation. Serum TNF-α and 1L-1β concentrations were detected at 0,6,24 and 72 h before and after the operation by the ELISA method. Oxygen indexes(OI) in aterial blood gas were detected at 0,6.24 and 72 h before and after the operation in both groups. Results: The serum levels of TNF-α and IL-1β, and OI had no significant difference between the two groups before the operation, tTNF-α = 1.357, P> 0.05, tIL-β = 1.41 P>0.05, and had a significant difference between the two groups after the operation, 0 h tTNF-α = 3.616, P< 0.01,tIL-β = 6.46, P<0.01; 6 h tTNF-α. 559, P<0.05, tIL-β =12.26, P<0.01;24 h tTNF-α =3.731, P<0.01, tIL-β- 0.23, P>0-05; 72 h after operation, tTNF-α = 1. 943, P> 0.05, tIL-β = 1.14, P>0.05. Ulinastatin could decrease the TNF-α and IL-β significantly. OI in ulinastatin group was increased significantly than that in control group (P<0.01). Conclusion: Ulinastatin can reduce the serum levels of TNF-α and IL-β significantly and has a certain protective effect on lung inflammatory reaction.
What problem does this paper attempt to address?